Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1610.15
-29.15 (-1.78%)
< Home < Back

Sun Pharmaceuticals Industries informs about press release

Date: 24-05-2017

Sun Pharmaceuticals Industries has informed about Press Release relating to US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab.

The above information is a part of company’s filings submitted to BSE.